Forget the outgoing year’s flavors of the week if you want to see sizable growth in your portfolio; instead, go the contrarian route and consider so-called underdog stocks. These may be the disappointments of 2023. Nevertheless, it’s sometimes the ideas that investors least expect that offer the biggest positive surprises. Let’s remind ourselves what happened
0 Comments
After lagging most sectors in 2023, healthcare stocks could deliver substantial returns in 2024. The market has been overly pessimistic about the sector due to short-term challenges. However, some healthcare stock picks have deep pipelines and trade at bargain valuations. In 2023, only GLP-1 makers Eli Lilly (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) saw substantial
0 Comments
Innovation in the medical world is undoubtedly a fundamental pillar in the development of humanity. There are great companies within the biotech sector doing wonderful work, research, and developments, not only to attack important diseases but also to prevent them. This backdrop has led to this list of biotech stocks to buy. Some of those
0 Comments
High-yielding stocks have always been an excellent source of passive income, and in most periods observed, they got better returns than the S&P 500. Entering the holiday season, investors will want to buy dividend stocks for passive income generation. A study by Wellington Management revealed that second-quintile stocks, with average dividend payouts, regularly outperformed the
0 Comments
Structural shifts in the financial markets have led to interesting strategic shifts among hedge fund managers. Although the hedge fund business is merely an enclave of the financial markets, its activities provide valuable insights to market participants. Hedge fund trades fuel any investment analysis; however, they should be placed into perspective. For those unaware, hedge
0 Comments
In the pulsating realm of small-cap stocks, a select few emerge as trailblazers, poised to revolutionize industries and redefine investment landscapes. Enter the triumphant trio of three under-the-radar companies orchestrating remarkable healthcare, biotechnology and cryptocurrency mining feats. Their ascent from modest beginnings to formidable players commanding markets offers a captivating saga of resilience, innovation and
0 Comments
While inflation is certainly coming under control in the United States, geopolitical shifts elsewhere will continue to be a strong determinant of U.S. equities performance. Geopolitical tensions between the United States and China as well as renewed conflict in the Middle East, including the Israel-Hamas War, could either benefit or seriously dent investors’ portfolios if
0 Comments
In this article, I will focus on established automakers rather than electric-vehicle startups. That’s because I’ve written a great deal about the latter firms in other recent columns. While EV startups are high-risk growth names, the automaker stocks I will present are lower-risk, growth-at-a-reasonable price (GARP) equities more suitable for older, conservative investors. Like all
0 Comments
As the tech landscape evolves, investors seek lucrative avenues for maximizing their investments. In 2025, the trajectories of key tech giants will beckon attention, promising substantial growth and innovation in AI and interactive media. The first pioneering endeavors in leveraging AI for advertising and business interactions. Whereas the second one’s strides in AI-centric solutions through
0 Comments
Income investing strategies stand out as a beacon for investors in the realm of health and stability. This approach, focusing on generating consistent cash flow through dividends or interest, remains a game-changer, especially in volatile markets. Such strategies not only offer regular income, critical for retirees but also diversify portfolios and reduce risk. These varied
0 Comments